0001209191-23-059344.txt : 20231220
0001209191-23-059344.hdr.sgml : 20231220
20231220163408
ACCESSION NUMBER: 0001209191-23-059344
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231218
FILED AS OF DATE: 20231220
DATE AS OF CHANGE: 20231220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cahill Brian Joseph
CENTRAL INDEX KEY: 0001831591
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36306
FILM NUMBER: 231501717
MAIL ADDRESS:
STREET 1: C/O EAGLE PHARMACEUTICALS, INC.
STREET 2: 50 TICE BOULEVARD, SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EAGLE PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000827871
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 TICE BOULEVARD, SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
BUSINESS PHONE: 201-326-5300
MAIL ADDRESS:
STREET 1: 50 TICE BOULEVARD, SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
FORMER COMPANY:
FORMER CONFORMED NAME: EAGLE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19880120
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-18
0
0000827871
EAGLE PHARMACEUTICALS, INC.
EGRX
0001831591
Cahill Brian Joseph
C/O EAGLE PHARMACEUTICALS, INC.
50 TICE BOULEVARD, SUITE 315
WOODCLIFF LAKE
NJ
07677
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-12-18
4
F
0
452
4.76
D
47416
D
The disposition reported on this Form 4 represents shares withheld by the Issuer to cover the tax liability upon the vesting of time-based restricted stock units previously granted and does not represent a discretionary transaction by the Reporting Person.
/s/ Brian Cahill
2023-12-20